[Federal Register Volume 85, Number 16 (Friday, January 24, 2020)]
[Notices]
[Page 4343]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01127]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a 
teleconference meeting of the Advisory Committee on the Medical Uses of 
Isotopes (ACMUI) on March 11, 2020, to discuss the draft report of the 
ACMUI Regulatory Guide 8.39 Subcommittee. A phased approach is being 
conducted by the NRC staff to comprehensively update Regulatory Guide 
8.39, ``Release of Patients Administered Radioactive Material.'' Phase 
1 of the revision provides licensees with more detailed instructions to 
patients before and after they have been administered radioactive 
material than what is currently provided in Regulatory Guide 8.39. The 
ACMUI subcommittee's report will include its comments and 
recommendations on the draft final Phase 1 revisions to Regulatory 
Guide 8.39. Meeting information, including a copy of the agenda and 
handouts, will be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2020.html. The agenda and handouts may also 
be obtained by contacting Ms. Kellee Jamerson using the information 
below.

DATES: The teleconference meeting will be held on Wednesday, March 11, 
2020, 2:00 p.m. to 4:00 p.m. Eastern Time.

FOR FURTHER INFORMATION CONTACT: Kellee Jamerson, email: 
[email protected], telephone: (301) 415-7408.

SUPPLEMENTARY INFORMATION: 
    Public Participation: Any member of the public who wishes to 
participate in the teleconference should contact Ms. Jamerson using the 
contact information in FOR FURTHER INFORMATION CONTACT.

Conduct of the Meeting

    Dr. Darlene Metter, ACMUI Chairman, will preside over the meeting. 
Dr. Metter will conduct the meeting in a manner that will facilitate 
the orderly conduct of business. The following procedures apply to 
public participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Jamerson at the contact information listed 
above. All written statements must be received by March 6, 2020, three 
business days prior to the meeting, and must pertain to the topic on 
the agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting at the discretion of the ACMUI Chairman.
    3. The draft transcript and meeting summary will be available on 
ACMUI's website http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2020.html on or about April 22, 2020.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in 10 
CFR part 7.

    Dated: January 17, 2020.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2020-01127 Filed 1-23-20; 8:45 am]
 BILLING CODE 7590-01-P